Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jimmy Ruiz

Showing results (51-60 of 99) with videos related to

Pageof 10
Sort By:
World Neurosurgery|October 21, 2023
Delayed Imaging Changes 18 Months or Longer After Stereotactic Radiosurgery for Brain Metastases: Necrosis or ProgressionMichelle M Williams, Arian K Sohrabi, Carol A Kittel, et al.
Cancers|May 13, 2023
c-Met Mediated Cytokine Network Promotes Brain Metastasis of Breast Cancer by Remodeling Neutrophil ActivitiesYin Liu, Margaret R Smith, Yuezhu Wang, et al.
Lung Cancer (Amsterdam, Netherlands)|January 16, 2019
Feasibility of lung cancer RNA acquisition from a single transbronchial or transthoracic needle pass (FASTT trial)Travis Dotson, Christina Bellinger, Jing Su, et al.
Clinical Neurology and Neurosurgery|November 24, 2018
Analysis of the drivers of cost of management when patients with brain metastases are treated with upfront radiosurgeryRachel F Shenker, Emory R McTyre, Glen B Taksler, et al.
Frontiers in Oncology|May 3, 2021
Comprehensive and Computable Molecular Diagnostic Panel (C2Dx) From Small Volume Specimens for Precision Oncology: Molecular Subtyping of Non-Small Cell Lung Cancer From Fine Needle AspiratesJing Su, Lynn S Huang, Ryan Barnard, et al.
The Oncologist|November 9, 2025
Phase Ib study of berzosertib, carboplatin, gemcitabine, and pembrolizumab in patients with squamous nonsmall lung cancer (ETCTN 10313)Liza C Villaruz, Benjamin Schluger, Hong Wang, et al.
Journal of Radiosurgery and SBRT|October 24, 2022
Upfront immunotherapy leads to lower brain metastasis velocity in patients undergoing stereotactic radiosurgery for brain metastasesMohammed Abdulhaleem, Emmanuel Scott, Hannah Johnston, et al.
NPJ Precision Oncology|March 27, 2023
Prognostic Mutational Signatures of NSCLC Patients treated with chemotherapy, immunotherapy and chemoimmunotherapyMargaret R Smith, Yuezhu Wang, Ralph D'Agostino, et al.
Neuro-Oncology Practice|March 27, 2023
Five-year survivors from brain metastases treated with stereotactic radiosurgery: Biology, improving treatments, or just plain luck?Jane B Pearce, Fang-Chi Hsu, Claire M Lanier, et al.
Neurosurgery|October 4, 2017
Staged Stereotactic Radiosurgery for Large Brain Metastases: Local Control and Clinical Outcomes of a One-Two Punch TechniqueAmmoren Dohm, Emory R McTyre, Catherine Okoukoni, et al.
Pageof 10

Showing results (51-60 of 99) with videos related to

Sort By:
Pageof 10
World Neurosurgery|October 21, 2023
Delayed Imaging Changes 18 Months or Longer After Stereotactic Radiosurgery for Brain Metastases: Necrosis or ProgressionMichelle M Williams, Arian K Sohrabi, Carol A Kittel, et al.
Cancers|May 13, 2023
c-Met Mediated Cytokine Network Promotes Brain Metastasis of Breast Cancer by Remodeling Neutrophil ActivitiesYin Liu, Margaret R Smith, Yuezhu Wang, et al.
Lung Cancer (Amsterdam, Netherlands)|January 16, 2019
Feasibility of lung cancer RNA acquisition from a single transbronchial or transthoracic needle pass (FASTT trial)Travis Dotson, Christina Bellinger, Jing Su, et al.
Clinical Neurology and Neurosurgery|November 24, 2018
Analysis of the drivers of cost of management when patients with brain metastases are treated with upfront radiosurgeryRachel F Shenker, Emory R McTyre, Glen B Taksler, et al.
Frontiers in Oncology|May 3, 2021
Comprehensive and Computable Molecular Diagnostic Panel (C2Dx) From Small Volume Specimens for Precision Oncology: Molecular Subtyping of Non-Small Cell Lung Cancer From Fine Needle AspiratesJing Su, Lynn S Huang, Ryan Barnard, et al.
The Oncologist|November 9, 2025
Phase Ib study of berzosertib, carboplatin, gemcitabine, and pembrolizumab in patients with squamous nonsmall lung cancer (ETCTN 10313)Liza C Villaruz, Benjamin Schluger, Hong Wang, et al.
Journal of Radiosurgery and SBRT|October 24, 2022
Upfront immunotherapy leads to lower brain metastasis velocity in patients undergoing stereotactic radiosurgery for brain metastasesMohammed Abdulhaleem, Emmanuel Scott, Hannah Johnston, et al.
NPJ Precision Oncology|March 27, 2023
Prognostic Mutational Signatures of NSCLC Patients treated with chemotherapy, immunotherapy and chemoimmunotherapyMargaret R Smith, Yuezhu Wang, Ralph D'Agostino, et al.
Neuro-Oncology Practice|March 27, 2023
Five-year survivors from brain metastases treated with stereotactic radiosurgery: Biology, improving treatments, or just plain luck?Jane B Pearce, Fang-Chi Hsu, Claire M Lanier, et al.
Neurosurgery|October 4, 2017
Staged Stereotactic Radiosurgery for Large Brain Metastases: Local Control and Clinical Outcomes of a One-Two Punch TechniqueAmmoren Dohm, Emory R McTyre, Catherine Okoukoni, et al.
Pageof 10